• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    14.09 0.52(3.83%) Dec 17, 4:00PM EST
    Add to Portfolio
    Prev Close:13.57
    Open:13.59
    Bid:13.75 x 200
    Ask:14.35 x 2600
    1y Target Est:24.15
    Beta:6.33
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:13.55 - 14.11
    52wk Range:11.53 - 18.48
    Volume:1,131,211
    Avg Vol (3m):1,578,660
    Market Cap:1.30B
    P/E (ttm):N/A
    EPS (ttm):-1.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 3.83%1.30B
    BAX39.17B
    SHPG42.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):121.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.15
    Quarterly EPS Est (Dec-14) :-0.37
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-0.41

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback